| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CinCor Pharma, Inc. | 10%+ Owner | Common Stock | 6,073,949 | $174,626,034 | $28.75 | 11 Aug 2022 | By Sofinnova Venture Partners X, L.P. |
| Aerovate Therapeutics, Inc. | 10%+ Owner | Common Stock | 3,758,686 | $73,294,377 | $19.50 | 02 Jul 2021 | Direct |
| Vera Therapeutics, Inc. | 10%+ Owner | Class A Common Stock | 3,467,156 | $62,408,808 | $18.00 | 06 Feb 2023 | Direct |
| Aerovate Therapeutics, Inc. | 10%+ Owner | Series A Preferred Stock | 0 | 02 Jul 2021 | Direct | ||
| CinCor Pharma, Inc. | 10%+ Owner | Series A Preferred Stock | 0 | 11 Jan 2022 | By Sofinnova Venture Partners X, L.P. | ||
| CinCor Pharma, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | 11 Jan 2022 | By Sofinnova Venture Partners X, L.P. |